EDP Sciences logo
Web of Conferences logo
Search
Menu
All issues Volume 622 (2025) E3S Web Conf., 622 (2025) 02009 References
Open Access
Issue
E3S Web Conf.
Volume 622, 2025
2nd International Conference on Environment, Green Technology, and Digital Society (INTERCONNECTS 2024)
Article Number 02009
Number of page(s) 15
Section Environmental and Health Science
DOI https://doi.org/10.1051/e3sconf/202562202009
Published online 04 April 2025
  1. M. Mander, L. Ntuli, N. Diederichs, and K. Mavundla, "Economics of the traditional medicine trade in South Africa care delivery," South African health review, vol. 2007, no. 1, pp. 189–196, 2007. [Google Scholar]
  2. V. P. Ana, "Economic impact of traditional medicine practice worldwide," Traditional Medicine Research, vol. 2, no. 2, p. 60, 2017. [Google Scholar]
  3. B. Patwardhan and A. D. Vaidya, "Ayurveda: scientific research and publications," Current Science, vol. 97, no. 8, pp. 1117–1121, 2009. [Google Scholar]
  4. Y. Feng, Z. Wu, X. Zhou, Z. Zhou, and W. Fan, "Knowledge discovery in traditional Chinese medicine: state of the art and perspectives," Artificial Intelligence in Medicine, vol. 38, no. 3, pp. 219–236, 2006. [Google Scholar]
  5. C.-T. Che, V. George, T. Ijinu, P. Pushpangadan, and K. Andrae-Marobela, "Traditional medicine," in Pharmacognosy: Elsevier, 2024, pp. 11–28. [Google Scholar]
  6. J. Gertsch, "How scientific is the science in ethnopharmacology? Historical perspectives and epistemological problems," Journal of ethnopharmacology, vol. 122, no. 2, pp. 177–183, 2009. [Google Scholar]
  7. M. Ekor, "The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety," Frontiers in pharmacology, vol. 4, p. 177, 2014. [Google Scholar]
  8. B. Patwardhan and A. Partwardhan, Traditional Medicine: Modern Approach for affordable global health. World Health Organization Switzerland, 2005. [Google Scholar]
  9. A. P. Cavender and S. H. Beck, "Generational change, folk medicine, and medical self- care in a rural Appalachian community," Human Organization, vol. 54, no. 2, pp. 129–142, 1995. [Google Scholar]
  10. W. H. Organization, WHO global report on traditional and complementary medicine 2019. World Health Organization, 2019. [Google Scholar]
  11. S.-Y. Pan et al., "New perspectives on how to discover drugs from herbal medicines: CAM′ S outstanding contribution to modern therapeutics," Evidence‐Based Complementary and Alternative Medicine, vol. 2013, no. 1, p. 627375, 2013. [Google Scholar]
  12. S. Bent and R. Ko, "Commonly used herbal medicines in the United States: a review," The American journal of medicine, vol. 116, no. 7, pp. 478–485, 2004. [Google Scholar]
  13. S. F. Ismail, M. Daud, J. A. Jalil, I. M. A. G. Azmi, and S. Safuan, "Protecting consumers from misleading online advertisement for herbal and traditional medicines in Malaysia: Are the laws sufficient?," in 2018 6th International Conference on Cyber and IT Service Management (CITSM), 2018: IEEE, pp. 1–6. [Google Scholar]
  14. S. Lapenna, R. Gemen, J. Wollgast, A. Worth, P. Maragkoudakis, and S. Caldeira, "Assessing herbal products with health claims," Critical Reviews in Food Science and Nutrition, vol. 55, no. 13, pp. 1918–1928, 2015. [Google Scholar]
  15. W. M. Bandaranayake, "Quality control, screening, toxicity, and regulation of herbal drugs," Modern phytomedicine: turning medicinal plants into drugs, pp. 25–57, 2006. [Google Scholar]
  16. S. Wachtel-Galor and I. F. Benzie, "Herbal medicine: an introduction to its history, usage, regulation, current trends, and research needs," 2012. [Google Scholar]
  17. F.-S. Li and J.-K. Weng, "Demystifying traditional herbal medicine with modern approach," Nature plants, vol. 3, no. 8, pp. 1–7, 2017. [Google Scholar]
  18. R. Satoskar and S. Bhandarkar, Pharmacology and pharmacotherapeutics. Elsevier India, 2020. [Google Scholar]
  19. K. E. Andersson, "PDE5 inhibitors–pharmacology and clinical applications 20 years after sildenafil discovery," Br. J. Pharmacol., vol. 175, no. 13, pp. 2554–2565, 2018. [Google Scholar]
  20. S. G. Moreira Jr, R. E. Brannigan, A. Spitz, F. J. Orejuela, L. I. Lipshultz, and E. D. Kim, "Side-effect profile of sildenafil citrate (Viagra) in clinical practice," Urology, vol. 56, no. 3, pp. 474–476, 2000. [Google Scholar]
  21. I. Karunarathna, K. De Alvis, P. Gunasena, and A. Jayawardana, "The impact of sildenafil on quality of life: Evidence from clinical studies," ed: ResearchGate. https://www.researchgate.net/publication…,2024. [Google Scholar]
  22. T. Aoyagi, K. Hayakawa, K. Miyaji, H. Ishikawa, and M. Hata, "Sildenafil induced priapism," The Bulletin of Tokyo Dental College, vol. 40, no. 4, pp. 215–217, 1999. [Google Scholar]
  23. A. L. Burnett, U. A. Anele, I. N. Trueheart, J. J. Strouse, and J. F. Casella, "Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease," The American journal of medicine, vol. 127, no. 7, pp. 664–668, 2014. [Google Scholar]
  24. S. L. Catterson, "Complementary and alternate medicines: a forensic analysis of the potential adulteration of over-the-counter anorectics and" lifestyle" medicines in South Africa," 2017. [Google Scholar]
  25. R. Tittarelli et al., "Hepatotoxicity of paracetamol and related fatalities," European Review for Medical and Pharmacological Sciences, vol. 21, no. 1 Suppl, pp. 95–101, 2017. [Google Scholar]
  26. S. B. Mahadevan, P. J. McKiernan, P. Davies, and D. A. Kelly, "Paracetamol induced hepatotoxicity," Archives of disease in childhood, vol. 91, no. 7, pp. 598–603, 2006. [Google Scholar]
  27. M. Kurowski, Adverse reactions to non-steroidal anti-inflammatory drugs: clinical pharmacoepidemiology. Birkhäuser, 2013. [Google Scholar]
  28. M. Worboys and E. Toon, "Phenylbutazone (Bute, PBZ, EPZ): One drug across two species," History and Philosophy of the Life Sciences, vol. 40, no. 2, p. 27, 2018. [Google Scholar]
  29. A. Prete and I. Bancos, "Glucocorticoid induced adrenal insufficiency," Bmj, vol. 374, 2021. [Google Scholar]
  30. J. Ai, L. Guo, Z. Zheng, S.-X. Wang, B. Huang, and X.-A. Li, "Corticosteroid therapy benefits septic mice with adrenal insufficiency but harms septic mice without adrenal insufficiency," Critical care medicine, vol. 43, no. 11, pp. e490–e498, 2015. [Google Scholar]
  31. I. Bancos, S. Hahner, J. Tomlinson, and W. Arlt, "Diagnosis and management of adrenal insufficiency," The lancet Diabetes & endocrinology, vol. 3, no. 3, pp. 216–226, 2015. [Google Scholar]
  32. R. Sarzani, F. Spannella, F. Giulietti, C. Di Pentima, P. Giordano, and A. Giacometti, "Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence," Internal and Emergency Medicine, vol. 17, no. 2, pp. 329–338, 2022. [Google Scholar]
  33. D. E. Arterburn, P. K. Crane, and D. L. Veenstra, "The efficacy and safety of sibutramine for weight loss: a systematic review," Archives of Internal Medicine, vol. 164, no. 9, pp. 994–1003, 2004. [Google Scholar]
  34. G. Williams, "Withdrawal of sibutramine in Europe," vol. 340, ed: British Medical Journal Publishing Group, 2010. [Google Scholar]
  35. S. Suparmi, S. Yuliyanti, H. W. Karyadini, A. M. Syamsudin, and E. K. Gau, "Toxicity of sibutramine hydrochloride-adulterated weight loss supplements in rats based on biochemical and organ weight parameters," Journal of Pharmacy & Pharmacognosy Research, vol. 12, no. 2, pp. 363–370, 2024. [Google Scholar]
  36. N. S. Chaudhary, M. A. Grandner, N. J. Jackson, and S. Chakravorty, "Caffeine consumption, insomnia, and sleep duration: Results from a nationally representative sample," Nutrition, vol. 32, no. 11-12, pp. 1193–1199, 2016. [PubMed] [Google Scholar]
  37. A. Morales, "Yohimbine in erectile dysfunction: the facts," International journal of impotence research, vol. 12, no. 1, pp. S70–S74, 2000. [Google Scholar]
  38. C. Anderson, D. Anderson, N. Harre, and N. Wade, "Case study: two fatal case reports of acute yohimbine intoxication," Journal of analytical toxicology, vol. 37, no. 8, pp. 611–614, 2013. [Google Scholar]
  39. R. Mosqueda-Garcia, Fernandez-Violante, J. Tank R., M. Snell, G. Cunningham, and R. Furlan, "Yohimbine in neurally mediated syncope. Pathophysiological implications," The Journal of clinical investigation, vol. 102, no. 10, pp. 1824–1830, 1998. [Google Scholar]
  40. E. Grossman and F. H. Messerli, "Secondary hypertension: interfering substances," The Journal of Clinical Hypertension, vol. 10, no. 7, pp. 556–566, 2008. [Google Scholar]
  41. L. Fortney, "The Pitfalls of Herbal Viagra," Integrative Medicine Alert, vol. 19, no. 6, 2016. [Google Scholar]
  42. C. M. Hossain, M. Gera, and K. A. Ali, "Current status and challenges of herbal drug development and regulatory aspect: a global perspective," Asian J. Pharm. Clin. Res, vol. 15, pp. 31–41, 2022. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.